• Lablink is the
largest
chain of private hospital
laboratories
in Malaysia
• Lablink is the
first
certified Biosafety Level 3
facilities
for private
laboratory in the country
• As at end-2015, Lablink’s
total manpower stood at
369 staff compared to
338 staff at end 2014,
of which
271 personnel
(73%)
are allied health
professionals
• Lablink has eight
consultant pathologists
including four visiting
consultants and
one
OSH-qualified Medical
Officer
LABORATORY SERVICES
Lablink (M) Sdn Bhd offers medical
laboratory services with a mission of
becoming the country’s preferred
laboratory service provider. Lablink has
been tasked with managing all of the
Group’s hospital laboratories, starting
with KPJ Ampang Puteri Specialist
Hospital in January 1999. To date,
Lablink operates the largest network of
private hospital laboratories in the
country, managing 23 KPJ hospital
laboratories in addition to its Main
Laboratory (Lablink Central) and a
laboratory in Nilai Medical Centre,
Negeri Sembilan.
The centralisation of laboratory services
under Lablink has standardised the
laboratory operating systems to be more
cost-efficient and provide comprehensive
medical specialist laboratory services.
Under the centralisation, all laboratories
are also linked through a Laboratory
Information System, which facilitates on
line test request, result and inventory
request. All of KPJ’s laboratories will
have access to Lablink Central for
technical, clinical and professional
consultation for each specialty. KPJ’s
consolidated laboratory services have
also helped the Group gain greater
recognition in the private medical
laboratory sector.
Following the launch of a transformation
programme in 2015, Lablink central has
been developed as a reference centre
for KPJ laboratories equipped with
world-class, state-of-the-art technology.
Lablink Central provides ample working
space and segregation between the
laboratory and the management office.
The completion of this first phase
development enable Lablink Central to
be certified with Biosafety Level 3
(BSL3) facilities according to WHO
standard which is the first for private
laboratory to achieve that in Malaysia.
With the BSL3 facilities, Lablink Central
able to handle and test the highly
infectious pathogenic agents such as
tuberculosis (“TB”) and Middle East
respiratory syndrome coronavirus (Mers-
CoV). Currently we have a comprehensive
TB Diagnostic Laboratory in the country
comprises of microscopy, culture,
sensitivity and molecular testing of
Mycobacterium.
With the completion of Molecular
Diagnostic Laboratory, Lablink Central
will transform the molecular diagnostic
testing facilities to Syndromic Molecular
Approach to serve the clinical needs. In
2015 Lablink Central also a National
Testing Centre for Mers-CoV PCR for
private healthcare facilities.
The centralisation of KPJ’s laboratory services under
Lablink has standardised the laboratory operating systems,
making them more cost efficient and more comprehensive
Medical Specialist
Laboratory Services
139
Annual Report
2015
KPJ Healthcare Berhad
Quick Facts
